Ablative Solutions announced today that it received positive results at six months from its post-market study for the Peregrine System infusion catheter, which accomplishes renal denervation by delivering microdoses of dehydrated alcohol.
The results from the study of the safety and efficacy of the CE-Marked Peregrine System have been published in the Journal of the American College of Cardiology: Cardiovascular Interventions.
